|
Volumn 21, Issue 3, 2009, Pages 347-349
|
Comorbidity in psychiatry: Its impact on psychopharmacological treatment
|
Author keywords
Comorbidity; Psychopharmacotherapy
|
Indexed keywords
NEUROLEPTIC AGENT;
ANXIETY;
ASTHMA;
BEHAVIOR THERAPY;
BIPOLAR DISORDER;
CARDIOVASCULAR DISEASE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COGNITIVE THERAPY;
COMORBIDITY;
CONFERENCE PAPER;
DEPRESSION;
DIABETES MELLITUS;
ENDOCRINE DISEASE;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
ISCHEMIA;
MENTAL DISEASE;
METABOLIC DISORDER;
MONOTHERAPY;
NEUROLOGIC DISEASE;
PALLIATIVE THERAPY;
POLYPHARMACY;
PSYCHIATRIC DIAGNOSIS;
PSYCHOPHARMACOTHERAPY;
PSYCHOSOMATIC DISORDER;
SCHIZOPHRENIA;
SUBSTANCE ABUSE;
TREATMENT RESPONSE;
ANTIPSYCHOTIC AGENTS;
COMBINED MODALITY THERAPY;
COMORBIDITY;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
HUMANS;
MENTAL DISORDERS;
PSYCHOTHERAPY;
PSYCHOTIC DISORDERS;
PSYCHOTROPIC DRUGS;
TREATMENT OUTCOME;
|
EID: 70350330531
PISSN: 03535053
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (7)
|